UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4714) 4714
Newsletter (131) 131
Dissertation (33) 33
Book Chapter (32) 32
Magazine Article (30) 30
Newspaper Article (29) 29
Publication (6) 6
Book Review (4) 4
Book / eBook (2) 2
Conference Proceeding (2) 2
Government Document (1) 1
Paper (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
sertraline (3017) 3017
science & technology (2905) 2905
humans (2837) 2837
life sciences & biomedicine (2814) 2814
male (1907) 1907
female (1821) 1821
psychiatry (1569) 1569
sertraline - therapeutic use (1486) 1486
adult (1381) 1381
biological and medical sciences (1189) 1189
medical sciences (1151) 1151
serotonin uptake inhibitors - therapeutic use (1078) 1078
middle aged (1061) 1061
pharmacology. drug treatments (916) 916
pharmacology & pharmacy (904) 904
treatment outcome (828) 828
antidepressive agents - therapeutic use (800) 800
psychology. psychoanalysis. psychiatry (785) 785
antidepressants (766) 766
psychopharmacology (698) 698
neuropharmacology (695) 695
neurosciences & neurology (645) 645
aged (624) 624
depression (622) 622
sertraline - adverse effects (616) 616
1-naphthylamine - analogs & derivatives (573) 573
serotonin uptake inhibitors - adverse effects (566) 566
depressive disorder - drug therapy (558) 558
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (549) 549
drug therapy (525) 525
adolescent (489) 489
animals (485) 485
double-blind method (484) 484
neurosciences (471) 471
depressive disorder, major - drug therapy (430) 430
psychology (426) 426
sertraline - pharmacology (422) 422
social sciences (419) 419
fluoxetine (404) 404
clinical neurology (398) 398
depression, mental (386) 386
serotonin uptake inhibitors - pharmacology (381) 381
sertraline - administration & dosage (369) 369
paroxetine (346) 346
research (340) 340
mental depression (337) 337
serotonin uptake inhibitors (333) 333
antidepressive agents - adverse effects (332) 332
serotonin (329) 329
psychiatric status rating scales (327) 327
psychopathology. psychiatry (325) 325
abridged index medicus (314) 314
dose-response relationship, drug (313) 313
depression - drug therapy (298) 298
care and treatment (292) 292
analysis (291) 291
1-naphthylamine - therapeutic use (290) 290
serotonin uptake inhibitors - administration & dosage (270) 270
citalopram (262) 262
adult and adolescent clinical studies (256) 256
clinical trials (254) 254
rats (250) 250
drug therapy, combination (247) 247
fluoxetine - therapeutic use (247) 247
child (241) 241
psychology, clinical (239) 239
drug interactions (219) 219
health aspects (219) 219
antidepressive agents - pharmacology (212) 212
paroxetine - therapeutic use (209) 209
1-naphthylamine - adverse effects (205) 205
depressive disorder - psychology (203) 203
anxiety (200) 200
young adult (199) 199
mood disorders (198) 198
general & internal medicine (194) 194
severity of illness index (192) 192
drugs (191) 191
dosage and administration (188) 188
medicine, general & internal (188) 188
antidepressive agents - administration & dosage (181) 181
comorbidity (181) 181
combined modality therapy (177) 177
time factors (176) 176
medicine & public health (175) 175
pediatrics (175) 175
ssris (172) 172
drug administration schedule (171) 171
toxicology (170) 170
ssri (166) 166
major depressive disorder (161) 161
obsessive-compulsive disorder - drug therapy (160) 160
risk factors (158) 158
fluvoxamine (155) 155
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer (153) 153
selective serotonin reuptake inhibitors (153) 153
citalopram - therapeutic use (151) 151
follow-up studies (148) 148
mental disorders (148) 148
aged, 80 and over (147) 147
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4780) 4780
Portuguese (47) 47
Spanish (47) 47
German (35) 35
Russian (30) 30
French (27) 27
Turkish (25) 25
Japanese (20) 20
Chinese (17) 17
Dutch (10) 10
Polish (8) 8
Czech (7) 7
Italian (5) 5
Norwegian (4) 4
Swedish (4) 4
Danish (3) 3
Hungarian (3) 3
Persian (3) 3
Croatian (2) 2
Hebrew (1) 1
Korean (1) 1
Romanian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International clinical psychopharmacology, ISSN 0268-1315, 07/2014, Volume 29, Issue 4, pp. 185 - 196
allosteric | selective serotonin reuptake inhibitor | serotonin | paroxetine | major depressive disorder | serotonin transporter | escitalopram (S-citalopram) | sertraline | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Mood disorders | Biological and medical sciences | Depression | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Paroxetine - pharmacokinetics | Antidepressive Agents, Second-Generation - adverse effects | Antidepressive Agents, Second-Generation - pharmacokinetics | Serotonin Uptake Inhibitors - pharmacokinetics | Citalopram - pharmacology | Depressive Disorder, Major - metabolism | Humans | Citalopram - adverse effects | Paroxetine - therapeutic use | Sertraline - adverse effects | Antidepressive Agents, Second-Generation - therapeutic use | Paroxetine - adverse effects | Depression - drug therapy | Serotonin Plasma Membrane Transport Proteins - chemistry | Depression - metabolism | Nerve Tissue Proteins - chemistry | Drug Interactions | Sertraline - pharmacokinetics | Sertraline - therapeutic use | Depressive Disorder, Major - drug therapy | Nerve Tissue Proteins - antagonists & inhibitors | Sertraline - pharmacology | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Antidepressive Agents, Second-Generation - pharmacology | Evidence-Based Medicine | Nerve Tissue Proteins - metabolism | Serotonin Plasma Membrane Transport Proteins - metabolism | Animals | Models, Biological | Allosteric Site | Citalopram - pharmacokinetics | Citalopram - therapeutic use | Paroxetine - pharmacology | Serotonin Uptake Inhibitors - pharmacology | Index Medicus | Review
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9789, pp. 403 - 411
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | General aspects | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Psychopathology. Psychiatry | Mood disorders | Biological and medical sciences | Depression | Medical sciences | Mianserin - adverse effects | Alzheimer Disease - complications | Double-Blind Method | Humans | Mianserin - therapeutic use | Depressive Disorder - drug therapy | Male | Mental Disorders - complications | Sertraline - adverse effects | Randomized Controlled Trials as Topic | Antidepressive Agents - therapeutic use | Mianserin - analogs & derivatives | Dementia - complications | Depressive Disorder - complications | Mental Disorders - drug therapy | Sertraline - therapeutic use | Aged, 80 and over | Mirtazapine | Female | Aged | Antidepressive Agents - adverse effects | Drug therapy | Comparative analysis | Sertraline | Health aspects | Depression, Mental | Dementia | Medical research | Antidepressants | Workers | Meetings | Health services | Mortality | Mental health | Clinical trials | Clinical medicine | Alzheimers disease | Index Medicus | Abridged Index Medicus | Drugs | Neurodegenerative diseases | Suicide | Side effects | technology assessment | Dementia disorders | Models | Alzheimer's disease | Psychiatry | sertraline
Journal Article
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 08/2002, Volume 288, Issue 6, pp. 701 - 709
Journal Article